Medicare Enrolled
Dr. Rajpreet Singh, D.O.
Rheumatology · College Station, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Rajpreet Singh is a rheumatology specialist in College Station, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 329,608 Medicare services across 3,049 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $13,091 from 54 pharmaceutical and/or device companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 0% volume in TX
$13,091 industry payments
Medicare Practice Summary
Medicare Utilization ↗329,608
Medicare services
Top 0% in TX for rheumatology
3,049
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,600 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
286,400 | $4 | $22 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
15,327 | $10 | $84 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,400 | $34 | $130 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,740 | $26 | $245 |
| Joint lubricant injection (GenVisc) An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
1,900 | $6 | $51 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,876 | $1 | $5 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
1,389 | $55 | $211 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
899 | $90 | $313 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
875 | $17 | $74 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
544 | $39 | $340 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
372 | $93 | $398 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
362 | $29 | $112 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
278 | $49 | $210 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
264 | $58 | $260 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
250 | $11 | $47 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
186 | $101 | $600 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
161 | $22 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $60 | $212 |
| Tuberculosis test, enumeration of t-cells A blood test that counts T-cells to help detect tuberculosis infection. |
126 | $97 | $308 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
125 | $13 | $57 |
| Measurement of dna antibody, single stranded | 125 | $12 | $50 |
| Rheumatoid factor level | 125 | $6 | $23 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
118 | $13 | $53 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
115 | $6 | $300 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
95 | $57 | $246 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $106 | $479 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
79 | $12 | $68 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
64 | $1 | $2 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
47 | $44 | $176 |
| Injection of carpal tunnel | 30 | $73 | $345 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
26 | $65 | $261 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
23 | $31 | $161 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $10 | $73 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
15 | $48 | $224 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.0% high complexity
89.0% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,091
Total received (2018-2024)
Avg $1,870/year across 7 years
Top 26% in TX for rheumatology
54
Companies
673
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,091 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,908
2023
$1,662
2022
$1,967
2021
$1,821
2020
$1,229
2019
$2,123
2018
$2,383
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,683
UCB, Inc.
$2,008
Novartis Pharmaceuticals Corporation
$954
Janssen Biotech, Inc.
$810
PFIZER INC.
$600
Boehringer Ingelheim Pharmaceuticals, Inc.
$484
Octapharma USA, Inc.
$472
Mallinckrodt Hospital Products Inc.
$431
Lilly USA, LLC
$391
AstraZeneca Pharmaceuticals LP
$385
E.R. Squibb & Sons, L.L.C.
$384
GlaxoSmithKline, LLC.
$345
Genentech USA, Inc.
$314
Radius Health, Inc.
$272
AbbVie Inc.
$238
GENZYME CORPORATION
$220
Celgene Corporation
$199
Aurinia Pharma U.S., Inc.
$151
ABBVIE INC.
$147
Horizon Therapeutics plc
$128
Antares Pharma, Inc.
$128
AbbVie, Inc.
$118
Janssen Scientific Affairs, LLC
$110
Organon Llc
$85
Organon LLC
$85
Alexion Pharmaceuticals, Inc.
$78
Merck Sharp & Dohme Corporation
$61
Bioventus LLC
$61
Hikma Pharmaceuticals USA
$59
Ultragenyx Pharmaceutical Inc.
$58
Mallinckrodt Enterprises LLC
$54
Sobi, Inc
$49
ANI Pharmaceuticals, Inc.
$48
Collegium Pharmaceutical, Inc.
$42
Sandoz Inc.
$37
Mallinckrodt LLC
$35
Pacira Pharmaceuticals Incorporated
$32
DePuy Synthes Sales Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$28
IDORSIA PHARMACEUTICALS US INC
$27
Mylan Institutional Inc.
$26
SANOFI-AVENTIS U.S. LLC
$24
Ferring Pharmaceuticals Inc.
$24
Horizon Pharma plc
$21
Fidia Pharma USA Inc.
$20
SOBI, INC
$19
Kiniksa Pharmaceuticals, Ltd.
$19
HOSPIRA, INC.
$16
Orthogenrx Inc.
$16
MEDEXUS PHARMA, INC.
$14
SCILEX PHARMACEUTICALS INC.
$14
Avanos Medical
$13
Avion Pharmaceuticals
$13
FIDIA PHARMA USA INC.
$12
Top 3 companies account for 43.1% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Belbuca · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · Durolane · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN 3 · GenVisc 850 · Gloperba · HADLIMA · HUMIRA · HYALGAN · HYRIMOZ · Hulio · Humira · Hymovis · ILARIS · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PANZYGA · PREVNAR 13 · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · Supartz FX Sodium Hyaluronate · TALTZ · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · Tymlos · ULTOMIRIS · Uloric · XELJANZ · XYOSTED · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
5
Per 100K population
2.1
County median income
$58,388
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER- COLLEGE STATI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Singh performed 286,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $13,091 from 54 companies across 673 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other rheumatologists in College Station?
Dr. Singh's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in College Station
Browse rheumatologists in College Station ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology